Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference47 articles.
1. Massoni, F., Simeone, C., Ricci, P., Onofri, E. & Ricci, S. Papillary thyroid carcinoma and medicolegal considerations. Minerva Med. 104, 493–494 (2013).
2. Han, S. A., Jang, J. H., Won, K. Y., Lim, S. J. & Song, J. Y. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma. Pathol. Res. Pract. 213, 956–963 (2017).
3. Ahn, S. H., Henderson, Y. C., Williams, M. D., Lai, S. Y. & Clayman, G. L. Detection of thyroid cancer stem cells in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 99, 536–544 (2014).
4. Giuffrida, R. et al. Resistance of papillary thyroid cancer stem cells to chemotherapy. Oncol. Lett. 12, 687–691 (2016).
5. Lin, Z. et al. Association of cancer stem cell markers with aggressive tumor features in papillary thyroid carcinoma. Cancer Control 22, 508–514 (2015).
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献